Centro Médico Teknon
Breast cancer treatment cost in Spain typically involves essential diagnostics like a PET/CT scan, which costs $1,300 to $1,800, and primary surgical interventions. Procedures such as a mastectomy run from $8,000 to $14,000, while breast cancer surgery ranges from $11,500 to $18,500. Total expenses depend on the disease stage and tumor type. Patients can achieve 30-50% savings compared to the US. Top cities for these treatments include Barcelona and Madrid.
Typical Breast Cancer Treatment Costs in Spain
Bookimed Expert Insight: For complex cases, patients benefit from multidisciplinary teams at JCI-accredited centers like Centro Médico Teknon. They offer specialized cancer packages starting around $3,500 including oncology consultations and preoperative tests. Patients seeking advanced research access should consider Quironsalud Madrid. It is the largest center by volume and offers free treatment via clinical trials for eligible individuals. Early-stage patients often choose Clinica Universidad de Navarra for its high limb and tissue preservation rates.
| Turcja | Austria | Hiszpania | |
| Tomoterapia | od $12,000 | od $30,000 | od $35,000 |
| Terapia protonowa przy raku piersi | od $30,000 | od $55,000 | od $85,000 |
| Terapia Aktynem-225 | od $22,955 | od $55,000 | od $45,000 |
| Radioterapia raka piersi | od $4,500 | od $10,000 | od $5,000 |
| Radioterapia raka odbytnicy | od $7,000 | od $12,000 | od $10,000 |
HM Hospitales — to grupa 7 wiodących hiszpańskich klinik zlokalizowanych w Madrycie (Hiszpania).
Specjalizacja — onkologia dorosłych i dzieci, neurologia, neurochirurgia, kardiologia i ortopedia.
W 2018 roku 5 spośród 7 szpitali znalazło się w TOP najlepszych prywatnych klinik w Hiszpanii według Organizacji Monitorowania Reputacji Medycznej MERCO.
Corocznie chirurdzy HM wykonują ponad 26 000 operacji, a leczenie raka przechodzi tutaj około 2 500 pacjentów.
Dr Agusti Barnadas Molins to czołowy specjalista w zakresie raka piersi w Instytucie Onkologii Teknon. Posiada 39-letnie doświadczenie w onkologii klinicznej oraz terapiach celowanych.
Dr. Enrique Grande, MD, PhD, MSc, is a medical oncologist with more than 20 years of experience. He is an international expert in genitourinary and neuroendocrine tumors. He directs the Medical Oncology Department and the One Oncology Madrid Cancer Program at QuirónSalud, Spain’s largest private healthcare network. He leads an integrated, multidisciplinary model with access to targeted therapies and clinical trials.
He is a pioneer in precision oncology. He uses molecular profiling and biomarker-based care. He has authored more than 300 peer-reviewed papers. He serves as a principal investigator and sits on steering committees for many international trials. These studies help set standards of care in urothelial bladder and neuroendocrine tumors. He contributes to guidelines and programs at ESMO, ASCO, ENETS, and EAU.
Dr Joseba Rebollo Liceaga wnosi ponad 35-letnie doświadczenie onkologiczne w leczenie raka piersi w Quironsalud Torrevieja.
Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.
She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.
She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.